Compare Novavax Inc (NVAX) vs Raymond James Financial, Inc. (RJF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Raymond James Financial, Inc. — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Raymond James Financial, Inc. trades at $168.25 (market cap $32.80B). The key difference: Raymond James Financial, Inc. is far larger — about 25.2× Novavax Inc's market cap, and Raymond James Financial, Inc. pays a 1.28% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | RJF | |
|---|---|---|
Market Cap | $1.30B | $32.80B |
Sector | Health | Financials |
52-Week High | $11.19 | $176.43 |
52-Week Low | $6.22 | $140.89 |
Enterprise Value | $800.50M | — |
Dividend Yield | — | 1.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $8.08, down 1.64% on the day, with a bearish technical signal but strong recent earnings beats. The company reported $1.12B revenue in 2025 with a net income of $440.30M, though 2026 projections show a return to losses. Analyst consensus is bullish with a $14.00 price target, but negative shareholder equity and cash flow concerns persist.
Outlook remains mixed: strong valuation ratios and analyst support suggest upside potential, but negative cash flows, high liabilities, and projected 2026 losses pose significant risks. Investor sentiment is cautious amid recent stock declines and shareholder dissent highlighted in recent news.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Raymond James Financial, Inc.
Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.
Read more on RJF →
